2.5-Diaminoadipinsaurediathylester | 732246-90-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2.5-Diaminoadipinsaurediathylester
• 英文别名: Diethyl 2,5-diaminohexanedioate
• CAS: 732246-90-1
• 化学式: C₁₀H₂₀N₂O₄
• 分子量: 232.28
• InChiKey: ZDCIBJJKQWQDQK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  16
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  105
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2.5-Diaminoadipinsaurediathylester 在 盐酸 、 氨 作用下， 生成 5-Amino-6-oxo-piperidine-2-carboxylic acid amide; hydrochloride
  参考文献：
  名称：

  The synthesis of symmetrical bis-1,2,5-thiadiazole ligands

  摘要：

  We have been engaged in a search for coordination catalysts for the copolymerization of polar monomers (such as vinyl chloride and vinyl acetate) with ethylene. We have been investigating complexes of late transition metals with heterocyclic ligands. In this report we describe the synthesis of a symmetrical bis-thiadiazole. We have characterized one of the intermediates using single crystal X-ray diffraction. Several unsuccessful approaches toward 1 are also described, which shed light on some of the unique chemistry of thiadiazoles. (C) 2004 lsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2004.05.045
• 作为产物：
  描述：

  2,5-二溴己二酸二乙酯 在 platinum(II) oxide 盐酸 、 sodium azide 、 氢气 作用下， 以 乙醇 为溶剂， 反应 17.0h， 生成 2.5-Diaminoadipinsaurediathylester
  参考文献：
  名称：

  The synthesis of symmetrical bis-1,2,5-thiadiazole ligands

  摘要：

  We have been engaged in a search for coordination catalysts for the copolymerization of polar monomers (such as vinyl chloride and vinyl acetate) with ethylene. We have been investigating complexes of late transition metals with heterocyclic ligands. In this report we describe the synthesis of a symmetrical bis-thiadiazole. We have characterized one of the intermediates using single crystal X-ray diffraction. Several unsuccessful approaches toward 1 are also described, which shed light on some of the unique chemistry of thiadiazoles. (C) 2004 lsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2004.05.045

文献信息

• Bridged piperazine derivatives
  申请人：Pfizer Inc.

  公开号：US20020119961A1

  公开（公告）日：2002-08-29

  A compound of the formula 1 or the pharmaceutically acceptable salt thereof; wherein a, c, d, k, l, m, W, X, Y Z, R 1 , and R 4 are as defined, and useful to treat inflammation and other immune disorders.

  一种具有化学式1或其药用可接受的盐的化合物；其中a、c、d、k、l、m、W、X、Y、Z、R1和R4如定义，并且可用于治疗炎症和其他免疫性疾病。
• Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
  申请人：Xie Wenge

  公开号：US20050176754A1

  公开（公告）日：2005-08-11

  The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds for example, indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

  本发明涉及尼古丁乙酰胆碱受体（nAChR）配体、nAChR的激活以及与缺陷或失灵的尼古丁乙酰胆碱受体相关的疾病情况的治疗，特别是大脑的疾病情况。此外，本发明还涉及新型化合物，例如吲哚、1H-吲唑、1,2-苯并异噁唑和1,2-苯并异硫嗪，它们作为α7 nAChR亚型的配体，制备这些化合物的方法，含有这些化合物的组合物以及其使用方法。
• INDOLES, 1H-INDAZOLES, 1,2-BENZISOXAZOLES, AND 1,2-BENZISOTHIAZOLES, AND PREPARATION AND USES THEREOF
  申请人：XIE Wenge

  公开号：US20090088437A1

  公开（公告）日：2009-04-02

  The present invention relates generally to the field of ligands for nicotinic acetylcholine receptors (nAChR), activation of nAChRs, and the treatment of disease conditions associated with defective or malfunctioning nicotinic acetylcholine receptors, especially of the brain. Further, this invention relates to novel compounds for example, indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, which act as ligands for the α7 nAChR subtype, methods of preparing such compounds, compositions containing such compounds, and methods of use thereof.

  本发明涉及尼古丁乙酰胆碱受体（nAChR）配体、nAChR的激活以及与缺陷或功能失调的尼古丁乙酰胆碱受体相关的疾病状态的治疗，特别是与大脑相关的疾病状态。此外，本发明涉及新型化合物，例如吲哚、1H-吲哚唑、1,2-苯并异噁唑和1,2-苯并异硫噻唑，它们作为α7 nAChR亚型的配体，制备这种化合物的方法，含有这种化合物的组合物以及使用这种化合物的方法。
• BRIDGED PIPERAZINE DERIVATIVES
  申请人：Pfizer Products Inc.

  公开号：EP1326867A2

  公开（公告）日：2003-07-16
• US7396833B2
  申请人：——

  公开号：US7396833B2

  公开（公告）日：2008-07-08